Search Results

Protected nucleotide G2608 in 23S rRNA confers resistance to oxazolidinones in E. coli.

• Authors : Xu J; Banting and Best Department of Medical Research, University of Toronto, Ont., Canada M5G 1L6.; Golshani A

Subjects: Drug Resistance/Drug Resistance/Drug Resistance/*drug effects ; Escherichia coli/Escherichia coli/Escherichia coli/*cytology ; Escherichia coli/Escherichia coli/Escherichia coli/*drug effects

• Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2005 Mar 11; Vol. 328 (2), pp. 471-6.Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print Cited Medium: Print ISSN: 0006-291X (Print)

Record details

Applied Science & Technology Full Text (H.W. Wilson)

Record details

AN INSIGHT INTO PRIVILEGED SCAFFOLDS IN TUBERCULOSIS: DEVELOPMENTAL ASPECTS AND IMPLICATIONS IN DRUG DESIGN.

• Authors : Shinde, Rani. A.; Suvarna, Vasanti. M.; Abhyankar, Arundhati. N.

Subjects: DRUG design; TUBERCULOSIS; DRUG development

• Source: Indian Drugs; Jan2022, Vol. 59 Issue 1, p7-22, 16p

Record details

Characterization of a Multiresistance Plasmid Carrying the optrA and cfr Resistance Genes From an Enterococcus faecium Clinical Isolate.

• Authors : Morroni, Gianluca; Brenciani, Andrea; Antonelli, Alberto

Subjects: MULTIDRUG resistance; OXAZOLIDINONES; ENTEROCOCCUS faecium

• Source: Frontiers in Microbiology; 9/11/2018, pN.PAG-N.PAG, 8p

Record details

Poly(ionic liquid)/Ce‐Based Antimicrobial Nanofibrous Membrane for Blocking Drug‐Resistance Dissemination from MRSA‐Infected Wounds.

• Authors : Luo, Zhenhong; Cui, Hengqing; Guo, Jiangna

Subjects: HORIZONTAL gene transfer; IONIC liquids; LABORATORY mice

• Source: Advanced Functional Materials; Jun2021, Vol. 31 Issue 23, p1-12, 12p

Record details

Agricola

Record details

University of Nebraska Medical Center Reports Findings in Methicillin-Resistant Staphylococcus aureus (Combination Therapy with Gallium Protoporphyrin and Gallium Nitrate Exhibits Enhanced Antimicrobial Activity In Vitro and In Vivo against...).

Subjects: METHICILLIN-resistant staphylococcus aureus; ACADEMIC medical centers; ANTI-infective agents

• Source: Food Weekly News; 8/3/2023, p234-234, 1p

Record details

Rhabdomyolysis in a Patient Treated With Linezolid for Extensively Drug-Resistant Tuberculosis.

• Authors : Carroll, Matthew W.; Choi, Hongjo; Min, Seonyeong

Subjects: RHABDOMYOLYSIS; STRIATED muscle necrosis; TUBERCULOSIS

• Source: Clinical Infectious Diseases; Jun2012, Vol. 54 Issue 11, p1624-1627, 4p

Record details

Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients.

• Authors : Koh, Won-Jung; Kang, Yeh Rim; Jeon, Kyeonman

Subjects: TUBERCULOSIS; OXAZOLIDINONES synthesis; NEUROTOXICOLOGY

• Source: Journal of Antimicrobial Chemotherapy (JAC); Jun2012, Vol. 67 Issue 6, p1503-1507, 5p

Record details

Sustainable Tuberculosis Drug Development.

• Authors : Wallis, Robert S.

Subjects: DRUG development; ANTITUBERCULAR agents; TUBERCULOSIS treatment

• Source: Clinical Infectious Diseases; Jan2013, Vol. 56 Issue 1, p106-113, 8p

Record details